Compare BLCO & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | VSAT |
|---|---|---|
| Founded | 1853 | 1986 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.6B |
| IPO Year | 2022 | 1996 |
| Metric | BLCO | VSAT |
|---|---|---|
| Price | $16.85 | $45.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | $18.55 | ★ $43.60 |
| AVG Volume (30 Days) | 429.4K | ★ 1.2M |
| Earning Date | 05-21-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.88 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $8.61 | $5.34 |
| Revenue Next Year | $5.52 | $3.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $10.45 | $7.36 |
| 52 Week High | $18.92 | $50.24 |
| Indicator | BLCO | VSAT |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | 49.16 |
| Support Level | $16.35 | $33.10 |
| Resistance Level | $16.81 | $46.43 |
| Average True Range (ATR) | 0.51 | 2.60 |
| MACD | -0.16 | -0.36 |
| Stochastic Oscillator | 1.24 | 26.56 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.